(Q41038497)

25 September 2017

Protection of mice against SV40 tumours by Pam3Cys, MTP-PE and Pam3Cys conjugated with the SV40 T antigen-derived peptide, K(698)-T(708). (English)

1 reference

25 September 2017

M Obert

1

1 reference

25 September 2017

H Pleuger

2

1 reference

25 September 2017

H G Hanagarth

3

1 reference

25 September 2017

J Schulte-Mönting

4

1 reference

25 September 2017

K H Wiesmüller

5

1 reference

25 September 2017

D G Braun

6

1 reference

25 September 2017

G Brandner

7

1 reference

25 September 2017

R D Hess

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

25 September 2017

1 reference

25 September 2017

16

1 reference

25 September 2017

2-3

1 reference

25 September 2017

161-169

1 reference

Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein).

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Relationship between T-antigen and tumor-specific transplantation antigen in simian virus 40-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Localization of an immunorecessive epitope on SV40 T antigen by H-2Db-restricted cytotoxic T-lymphocyte clones and a synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Localization of common cytotoxic T lymphocyte recognition epitopes on Simian papovavirus sv40 and human papovavirus JC virus T antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

The cell-binding carboxyterminal undecapeptide of SV40 tumour antigen provides protective cell-dependent immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Quantitative cytofluorimetric determination of cell membrane-associated large tumor antigen on SV40-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Induction of tumor cytotoxicity in murine bone marrow-derived macrophages by two synthetic lipopeptide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Incomplete functional differentiation of HL-60 leukemic cells by synthetic lipopeptides. Partial inhibition by pertussis toxin of enhanced superoxide formation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Induction and activity of NO synthase in bone-marrow-derived macrophages are independent of Ca2+

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

On closed testing procedures with special reference to ordered analysis of variance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Synthetic lipopeptides as novel adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Induction of tumouricidal leucocytes by the intranasal application of MTP-PE, a lipophilic muramyl peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

The Lipophilic Muramyl Peptide MTP-PE Is a Potent Inhibitor of HIV Replication in Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Production of soluble MHC class II proteins with covalently bound single peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

Peptide vaccination against cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2897%2900181-3

7 January 2021

10.1016/S0264-410X(97)00181-3

Identifiers

DOI

1 reference

25 September 2017

1 reference